Eiger BioPharmaceuticals 뉴스 - EIGR

기업명	주식 심볼	시장	주식 타입
Eiger BioPharmaceuticals Inc	EIGR	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.00	0.00%	1.725	09:00:00

개장가	저가	고가	종가	전일 종가
			1.725	1.725

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
02/04/2024	00:12	GLOBE	Eiger BioPharmaceuticals Files for Voluntary Chapter 11..
12/03/2024	05:03	EDGAR2	Form 8-K - Current report
25/01/2024	06:59	EDGAR2	Form 8-K - Current report
19/01/2024	07:49	PRNUS	Eiger and Partner, AnGes, Receive Approval for Zokinvy®..
08/01/2024	21:00	EDGAR2	Form 8-K - Current report
04/01/2024	22:45	EDGAR2	Form 8-K - Current report
04/01/2024	22:00	PRNUS	Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse..
12/12/2023	06:01	EDGAR2	Form DEF 14A - Other definitive proxy statements
04/12/2023	20:01	EDGAR2	Form SC 13D/A - General statement of acquisition of..
02/12/2023	06:02	EDGAR2	Form PRE 14A - Other preliminary proxy statements
24/11/2023	20:01	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
14/11/2023	06:01	EDGAR2	Form 8-K - Current report
10/11/2023	06:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/2023	06:14	EDGAR2	Form 8-K - Current report
10/11/2023	06:05	PRNUS	Eiger BioPharmaceuticals Reports Third Quarter 2023..
03/11/2023	10:54	EDGAR2	Form SC 13D/A - General statement of acquisition of..
03/11/2023	10:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
31/10/2023	05:51	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
21/10/2023	05:29	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
29/09/2023	05:54	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
13/09/2023	06:17	DJN	Eiger BioPharmaceuticals to Discontinue Chronic Hepatitis..
13/09/2023	05:42	EDGAR2	Form 8-K - Current report
13/09/2023	05:05	PRNUS	Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon..
06/09/2023	10:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
06/09/2023	10:35	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
06/09/2023	05:05	PRNUS	Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th..
15/08/2023	19:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
15/08/2023	05:24	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/2023	05:09	EDGAR2	Form 8-K - Current report
15/08/2023	05:05	PRNUS	Eiger BioPharmaceuticals Reports Second Quarter 2023..
29/07/2023	05:17	EDGAR2	Form 8-K - Current report
08/07/2023	05:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
07/07/2023	06:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
01/07/2023	05:16	EDGAR2	Form 8-K - Current report
29/06/2023	21:00	PRNUS	Eiger BioPharmaceuticals to Focus on Metabolic Diseases with..
29/06/2023	05:05	PRNUS	Eiger BioPharmaceuticals to Host Business Update Call..
12/05/2023	05:00	PRNUS	Eiger BioPharmaceuticals Reports First Quarter 2023..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

EIGR Eiger BioPharmaceuticals Inc

최근 뉴스

EIGR 과거 데이터 - 1일

EIGR 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Eiger BioPharmaceuticals Inc (EIGR) 뉴스

EIGR Eiger BioPharmaceuticals Inc

최근 뉴스

EIGR 과거 데이터 - 1일

EIGR 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기